河南省肿瘤诊疗质量控制中心乳腺癌规范化病理诊断专家共识  

Expert consensus of Henan Cancer Diagnostic and Treatment Quality Control Center on standardized pathological diagnosis for breast cancer

作　　者：河南省肿瘤诊疗质量控制中心乳腺癌专家委员会 张冰 夏庆欣 Breast Cancer Expert Committee of Henan Cancer Diagnostic and Treatment Quality Control Center(Affiliated Cancer Hospital of Zhengzhou University,Zhengzhou,Henan450008,China)

机构地区：[1]郑州大学附属肿瘤医院,河南郑州450008 [2]不详

出　　处：《中华肿瘤防治杂志》2023年第24期1507-1512,共6页Chinese Journal of Cancer Prevention and Treatment

摘　　要：乳腺癌的发病率位居女性恶性肿瘤的首位。随着医疗水平的提高,乳腺癌已经成为疗效最佳的实体肿瘤之一。规范化的乳腺癌病理报告,对于临床选择合适而有效的手术方式及治疗方案尤为重要。但在实际病理诊断工作中,很多方面仍然存在不规范的情况,特别是新辅助治疗后的标本取材及病理诊断等方面。为推动河南省乳腺癌的规范化诊治,由河南省肿瘤诊疗质量控制中心乳腺癌专家委员会参照国内外的乳腺癌相关诊疗指南制定了本共识。The incidence of breast cancer ranks first among female malignancies.With the improvement of medicine,breast cancer has become one of the solid tumors with the best efficacy.Standardized pathological report of breast cancer is particularly important for the clinical selection of appropriate and effective surgical methods and treatment plans.However,in the actual pathological diagnosis,there are still irregularities in many aspects,especially the specimen materials and pathological diagnosis after neoadjuvant treatment.In order to promote the standardized diagnosis and treatment of breast cancer in Henan Province,this consensus was formulated by Breast Cancer Expert Committee of Henan Cancer Diagnostic and Treatment Quality Control Center with reference to domestic and foreign guidelines for the diagnosis and treatment of breast cancer.

关 键 词：乳腺癌/诊断 病理学 病理申请单 标本取材 前哨淋巴结 免疫组织化学 共识 

分 类 号：R737.9[医药卫生—肿瘤]